KZA kazia therapeutics limited

Ann: Appendix 4C - quarterly, page-8

  1. 5,714 Posts.
    lightbulb Created with Sketch. 1749
    It mentions having made one-off costs for the setup of AGILE. No info about future costs. The report is deliberately obscure about future spending IMHO, no doubt due to it also stating they are pursuing funding options. Just being pedantic.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.